ResearcherDalhousie UniversityActive in the last 2 years
Jeanette E. Boudreau
Matched on ORCID iD 0000-0003-0203-2180; OpenAlex author ID A5088189511. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 3 papers
Papers 6
- Natural killer cell immunotherapy for pancreatic cancer: Release the brakes. First author DOI 10.1016/j.omton.2026.201223↗
- Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition. Last author DOI 10.1136/jitc-2025-013796↗
- Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol33020088↗
- Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fimmu.2025.1730817↗
- Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1071751↗
- PAXgene Fixation for Pancreatic Cancer: Implications for Molecular and Surgical Pathology. Co-author DOI 10.3390/jcm11144241↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stacey N. Lee · 4 shared papers, 2022–2026 · strength 1.44
- Paper Natural killer cell immunotherapy for pancreatic cancer: Release the brakes. DOI 10.1016/j.omton.2026.201223↗
- Paper Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors an… DOI 10.1136/jitc-2025-013796↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Thomas Arnason · 4 shared papers, 2022–2026 · strength 1.07
- Paper Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors an… DOI 10.1136/jitc-2025-013796↗
- Paper Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. DOI 10.3390/curroncol33020088↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Riley J. Arseneau · 2 shared papers, 2025–2026 · strength 0.67
- Ravi Ramjeesingh · 2 shared papers, 2025–2026 · strength 0.50
- Boris Gala-López · 2 shared papers, 2025–2026 · strength 0.50
- Thomas Samson · 2 shared papers, 2025–2026 · strength 0.50
- Sharon E. Clarke · 1 shared paper, 2026 · strength 0.26
- Carley Bekkers · 1 shared paper, 2025 · strength 0.24
- Sarah Mansouri · 1 shared paper, 2023 · strength 0.19
- Lee‐Hwa Tai · 1 shared paper, 2023 · strength 0.19
- Ryan C. DeCoste · 1 shared paper, 2022 · strength 0.14
- Weei‐Yuarn Huang · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.